Product Information

TOBRAMYCIN 0.3% EYE DROP is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $1.0708 per ML under NDC 62332051805. Its NADAC has been published 379 times since Aug 21, 2019.

FDA first approved this application on Apr 19, 2019. Its Orange Book therapeutic-equivalence code is AT.

TOBRAMYCIN 0.3% EYE DROP

Tobramycin Ophthalmic Solution
$1.0708per ML

Strength

3 mg/mL

NDC

62332051805

Classification

Generic

Dosage Form

SOLUTION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

TOBRAMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA211847

FDA Approved

4/19/2019

TE Code

AT

On Market Since

4/19/2019

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 0.3% EYE DROP has been published 379 times since Aug 21, 2019, and over the history we have for it it has declined 15.1%. The table below summarizes its recorded NADAC range and movement.

Current price$1.0708 per ML
All-time high$1.8050 (Sep 14, 2022)
All-time low$0.7286 (Jul 17, 2024)
52-week high$1.1579
52-week low$1.0024
Median price$1.3071
Average price$1.2904
Largest weekly change+63.0% (Jun 19, 2024)
Weeks tracked379
Tracking sinceAug 21, 2019

Price History

1W

-2.3%

1M

-3.4%

3M

-7.5%

6M

+5.3%

1Y

+3.2%

3Y

-13.1%

5Y

-14.9%

All

-15.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Tobramycin Ophthalmic Solution market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 0.3% EYE DROP?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 0.3% EYE DROP, manufactured by Alembic Pharmaceuticals Inc., is $1.0708 per ML (NDC 62332051805), effective Nov 18, 2026.

How has the price of TOBRAMYCIN 0.3% EYE DROP changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 0.3% EYE DROP has declined 15.1%. It has been tracked across 379 weekly CMS publications since Aug 21, 2019.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 0.3% EYE DROP?

Since Aug 21, 2019, the NADAC for TOBRAMYCIN 0.3% EYE DROP has ranged from a low of $0.7286 (Jul 17, 2024) to a high of $1.8050 (Sep 14, 2022), with a median of $1.3071 per ML.

Are there cheaper alternatives to TOBRAMYCIN 0.3% EYE DROP?

No other NADAC-published product currently shares the active ingredient and strength of TOBRAMYCIN 0.3% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures TOBRAMYCIN 0.3% EYE DROP?

TOBRAMYCIN 0.3% EYE DROP (NDC 62332051805) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.